the continuous or uninterrupted administration of the pharmaceutical composition of the invention may be intravenous or subcutaneous by way of a fluid delivery device or small pump system including a fluid driving mechanism for driving fluid out of a reservoir and an actuating mechanism for actuating the driving mechanism
Ingrdients: Ingrdient : Glutathion, arbutine, extrait de fruit de Pyrus Malus (pomme), acide linolique, acide linolnique, actate de tocophriel (actate de vitamine E), extrait de feuille d'aloe vera biologique (Aloe Vera), extrait d'Undaria Pinnatifida (algue), extrait de fruit de Punica Granatum (grenade), extrait de ppins de Vitis Vinifera (raisin), extrait de ppins de Daucus Carola Saliva (carotte), hydroxythylcellulose, huile parfume
Protect your joints
Disclosures: Alexandra McCullough: Nothing to Disclose, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Nadim Mahmud: Nothing to Disclose 2203 THE ASSOCIATION BETWEEN ALBUMIN ADMINISTRATION AND ACUTE KIDNEY INJURY OUTCOMES IN PATIENTS HOSPITALIZED WITH SPONTANEOUS BACTERIAL PERITONITIS Marina Serper 1 Alexandra McCullough 2 David Kaplan 3 Nadim Mahmud 2 , 1 University of Pennsylvania Health System, 2 Hospital of the University of Pennsylvania, 3 University of Pennsylvania Background: Patients who have cirrhosis decompensated by ascites are at risk for spontaneous bacterial peritonitis (SBP)
